Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andreas Helke who wrote (23607)	7/27/1998 9:31:00 PM
From: tonyt	Respond to of 32384

I guess LGND is just 'different' from other stocks.

To: Andreas Helke who wrote (23607)	7/27/1998 9:38:00 PM
From: Henry Niman	Respond to of 32384

The $14.55 was based on 50 million shares. LGND has quite a bit of additional technology and the big boys are in need of better pipelines. I expect more partnerships on more favorable terms to LGND. The big boys have the cash, but LGND has a major lead in technology and data bases. The picture should continue to improve. The street has trouble putting a value on this future technology, which is another reason that LGND is cheap at $20.